Cargando…

Defensive effect of microRNA-200b/c against amyloid-beta peptide-induced toxicity in Alzheimer's disease models

MiRNA molecules are important post-transcriptional regulators of gene expression in the brain function. Altered miRNA profiles could represent a defensive response against the pathogenesis of neurodegenerative disorders, such as Alzheimer's disease (AD). Endogenous miRNAs have lower toxic effec...

Descripción completa

Detalles Bibliográficos
Autores principales:	Higaki, Sayuri, Muramatsu, Masashi, Matsuda, Akio, Matsumoto, Kenji, Satoh, Jun-ichi, Michikawa, Makoto, Niida, Shumpei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5940223/ https://www.ncbi.nlm.nih.gov/pubmed/29738527 http://dx.doi.org/10.1371/journal.pone.0196929

Ejemplares similares

Plasma microRNA biomarker detection for mild cognitive impairment using differential correlation analysis
por: Kayano, Mitsunori, et al.
Publicado: (2016)

MicroRNA-Seq Data Analysis Pipeline to Identify Blood Biomarkers for Alzheimer’s Disease from Public Data
por: Satoh, Jun-ichi, et al.
Publicado: (2015)

Inflammation-induced endothelial cell-derived extracellular vesicles modulate the cellular status of pericytes
por: Yamamoto, Seiji, et al.
Publicado: (2015)

Identification of potential blood biomarkers for early diagnosis of Alzheimer’s disease through RNA sequencing analysis
por: Shigemizu, Daichi, et al.
Publicado: (2020)

JAMIR-eQTL: Japanese genome-wide identification of microRNA expression quantitative trait loci across dementia types
por: Akiyama, Shintaro, et al.
Publicado: (2021)

MicroRNA transcriptome analysis on hypertrophy of ligamentum flavum in patients with lumbar spinal stenosis
por: Mori, Taiki, et al.
Publicado: (2017)

Network‐based meta‐analysis and the candidate gene association studies reveal novel ethnicity‐specific variants in MFSD3 and MRPL43 associated with dementia with Lewy bodies
por: Shigemizu, Daichi, et al.
Publicado: (2022)

The novel amyloid-beta peptide aptamer inhibits intracellular amyloid-beta peptide toxicity
por: Wang, Xu, et al.
Publicado: (2013)

Prognosis prediction model for conversion from mild cognitive impairment to Alzheimer’s disease created by integrative analysis of multi-omics data
por: Shigemizu, Daichi, et al.
Publicado: (2020)

Alzheimer’s disease pathology propagation by exosomes containing toxic amyloid-beta oligomers
por: Sardar Sinha, Maitrayee, et al.
Publicado: (2018)

A possible mechanism for the enhanced toxicity of beta-amyloid protofibrils in Alzheimer’s disease
por: Chen, Zu-Lin, et al.
Publicado: (2023)

Ethnic and trans-ethnic genome-wide association studies identify new loci influencing Japanese Alzheimer’s disease risk
por: Shigemizu, Daichi, et al.
Publicado: (2021)

Beta-amyloid increases the expression level of ATBF1 responsible for death in cultured cortical neurons
por: Jung, Cha-Gyun, et al.
Publicado: (2011)

Delphinidin, One of the Major Anthocyanidins, Prevents Bone Loss through the Inhibition of Excessive Osteoclastogenesis in Osteoporosis Model Mice
por: Moriwaki, Sawako, et al.
Publicado: (2014)

Oxidation destabilizes toxic amyloid beta peptide aggregation
por: Razzokov, J., et al.
Publicado: (2019)

Tyramine and Amyloid Beta 42: A Toxic Synergy
por: Dhakal, Sudip, et al.
Publicado: (2020)

Differential Effects of Endocannabinoids on Amyloid-Beta Aggregation and Toxicity
por: Khavandi, Marzie, et al.
Publicado: (2023)

Screening for Novel Inhibitors of Amyloid Beta Aggregation and Toxicity as Potential Drugs for Alzheimer’s Disease
por: Sharari, Sanaa, et al.
Publicado: (2023)

Amyloid-beta and Alzheimer’s disease: the role of neprilysin-2 in amyloid-beta clearance
por: Marr, Robert A., et al.
Publicado: (2014)

The Protective Role of microRNA-200c in Alzheimer's Disease Pathologies Is Induced by Beta Amyloid-Triggered Endoplasmic Reticulum Stress
por: Wu, Qi, et al.
Publicado: (2016)

New amyloid plaques or a game of hide-and-seek?
por: Zou, Kun, et al.
Publicado: (2008)

Amyloid-beta Alzheimer targets — protein processing, lipid rafts, and amyloid-beta pores
por: Arbor, Sage C., et al.
Publicado: (2016)

A Toxic Synergy between Aluminium and Amyloid Beta in Yeast
por: Mcdonald, Jamieson B., et al.
Publicado: (2021)

Allium roseum L. extract inhibits amyloid beta aggregation and toxicity involved in Alzheimer’s disease
por: Boubakri, Abdelbasset, et al.
Publicado: (2020)

Novel plasma biomarker surrogating cerebral amyloid deposition
por: KANEKO, Naoki, et al.
Publicado: (2014)

Association Between Appetite and Sarcopenia in Patients With Mild Cognitive Impairment and Early-Stage Alzheimer's Disease: A Case-Control Study
por: Kimura, Ai, et al.
Publicado: (2018)

Amyloid Beta in Aging and Alzheimer’s Disease
por: Sehar, Ujala, et al.
Publicado: (2022)

Alzheimer’s Amyloid β Peptide Induces Angiogenesis in an Alzheimer’s Disease Model Mouse through Placental Growth Factor and Angiopoietin 2 Expressions
por: Sheikh, Abdullah Md., et al.
Publicado: (2023)

Angiotensin type 1a receptor deficiency decreases amyloid β-protein generation and ameliorates brain amyloid pathology
por: Liu, Junjun, et al.
Publicado: (2015)

Phosphorylation of amyloid beta (Aβ) peptides – A trigger for formation of toxic aggregates in Alzheimer's disease
por: Kumar, Sathish, et al.
Publicado: (2011)

The Protective Role of Carnosic Acid against Beta-Amyloid Toxicity in Rats
por: Rasoolijazi, H., et al.
Publicado: (2013)

Amyloid Beta: Multiple Mechanisms of Toxicity and Only Some Protective Effects?
por: Carrillo-Mora, Paul, et al.
Publicado: (2014)

Atomic resolution map of the soluble amyloid beta assembly toxic surfaces
por: Ahmed, Rashik, et al.
Publicado: (2019)

Toxicities of amyloid-beta and tau protein are reciprocally enhanced in the Drosophila model
por: Sun, Zhen-Dong, et al.
Publicado: (2022)

Controlling Amyloid Beta Peptide Aggregation and Toxicity by Protease-Stable Ligands
por: Mallesh, Rathnam, et al.
Publicado: (2023)

Potential Therapeutic Approaches for Cerebral Amyloid Angiopathy and Alzheimer’s Disease
por: Tanaka, Masashi, et al.
Publicado: (2020)

Editorial on, “Amyloid-beta clearance in Alzheimer's disease”
por: Marr, Robert A.
Publicado: (2014)

Amyloid Beta and MicroRNAs in Alzheimer’s Disease
por: Amakiri, Nnana, et al.
Publicado: (2019)

Amyloid-beta immunotherapy: the hope for Alzheimer disease?
por: Barrera-Ocampo, Alvaro, et al.
Publicado: (2016)

Lipidomic analysis of brain tissues and plasma in a mouse model expressing mutated human amyloid precursor protein/tau for Alzheimer’s disease
por: Tajima, Yoko, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_b95fq151s6s1v64aogi21eqmfi